Cost-effectiveness of tolvaptan in autosomal dominant polycystic kidney disease. Annals of internal medicine Erickson, K. F., Chertow, G. M., Goldhaber-Fiebert, J. D. 2014; 160 (2): 143-?

View details for DOI 10.7326/L14-5001-7

View details for PubMedID 24445704

View details for PubMedCentralID PMC4096316